N. N. Kasatkina

N. N. Kasatkina

Auto-generated profile, based on publicly available information

N. N. Kasatkina

N.N. Blokhin National Medical Research Center of Oncology, Ministry of Health of Russia

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 May 2018 in Advances in molecular oncology
Verified
Journal Article
Open access
PDF file
ASA. A. Solodovnik
A. A. Solodovnik
HMH. S. Mkrtchyan
H. S. Mkrtchyan
VMV. A. Misyurin
V. A. Misyurin
VTV. V. Tikhonova
V. V. Tikhonova
YFYu. P. Finashutina
Yu. P. Finashutina
ЮРЮ. Е. Рябухина
Ю. Е. Рябухина
Objective: to study the prognostic significance of the expression of cancer-testis (CT) genes PRAME, NY-ESO1, GAGE1, MAGE A3, MAGE A6, MAGE A12, SSX1, SLLP1, PASD1 in patients with multiple myeloma (MM) and their influence on overall survival and relapse rate. To determine their effect on suсh clinical parameters as levels of lactate dehydrogenase, leucocytes, hemoglobin, calcium, albumen, creatinine, beta-2-microglobulin.Materials and methods. Real-time polymerase chain reaction was performed on complementary DNA obtained from bone marrow of 77 patients with MM. The statistical analysis was performed using the Statistica 10.0 software package. To estimate prognostic values of the CT gene expression data were analyzed by the Kaplan – Meier method.Results. The study was conducted to determine the level of expression of CT genes PRAME, NY-ESO1, GAGE1, MAGE A3, MAGE A6, MAGE A12, SSX1, SLLP1, PASD1 in a group of patients with MM. The group included primary and receiving cancer treatment in MM patients. According to the log-rank criterion expression of any of the CT genes PRAME, NY-ESO1, GAGE1, MAGE A3, MAGE A6, MAGE A12, SSX1, SLLP1, PASD1 exerts a significant influence on overall survival and progression-free survival/relapse. It was also determined that providing expression of some CT genes, the levels of creatinine, calcium, beta-2-microglobulin were much higher to compare with patients without expression.

19 April 2019 in Russian Journal of Biotherapy
Verified
Journal Article
Open access
PDF file
ASA. A. Solodovnik
A. A. Solodovnik
АMА. S. Mkrtchyan
А. S. Mkrtchyan
VMV. A. Misyurin
V. A. Misyurin
LKL. A. Kesaeva
L. A. Kesaeva
NKN. N. Kasatkina
N. N. Kasatkina
ОЯО. Ю. Якимович
О. Ю. Якимович
Background . Multiple myeloma (MM) is a malignant lymphoproliferative B-cell disease characterization by clonal proliferation of plasma cells in the bone marrow and beyond its borders. Currently, a wide range of cytogenetic anomalies and molecular-biological parameters are studied as prognostic factors.Objective: a comparative study of the frequency, features and clinical significance of chromosomal abnormalities in MM by conventional cytogenetic and fluorescent in situ hybridization (FISH) methods.Materials and methods . 77 patients with MM, which admitted in N.N. Blokhin National Medical Research Center of Oncology, were included in the study from 2016 to 2017.Results . Chromosomal alterations were detected only in one case (1/77) by conventional cytogenetic method G-banding. However cytogenetic aberrations were revealed in 26 % of cases (20/77) using FISH. Deletions of different regions of chromosomes, indicating the possible presence of a hypodiploid clone or loss of some regions, were found in one patient in the second FISH analysis after 6 months. In the cohort of patients with chromosomal abnormalities (n = 20) a partial trisomy 11q, a deletion of the region q32 of the chromosome 14, a translocation t(4;14)(p16;q32) and IGHV gene rearrangement were determined in 30 % (6/20) as sole anomalies. Two or more cytogenetic aberrations were identified in the remaining 14 patients. Our study confirms that chromosomal abnormalities are more likely detected at later stages of MM (IA и IIA – 0 %, IIIA и IIIВ – 27 and 47 % respectively).Conclusion . FISH allows to detect chromosomal changes in tumor plasma cells regardless of the mitosis phase. In MM, it becomes particularly important in connection with low proliferative activity of plasma cells. Additionally, in the fourth of MM patients in the study submicroscopic chromosomal aberrations were discovered using FISH. The improvement of the probe panel and the widespread use of locus specific FISH don’t replace G-banding that allows to see damages of all chromosomes at once.

15 July 2025 in Russian Journal of Biotherapy
Verified
Journal Article
Open access
PDF file
OBO. A. Bocharova
O. A. Bocharova
AAA. A. Aksyonov
A. A. Aksyonov
RKR. V. Karpova
R. V. Karpova
EBE. V. Bocharov
E. V. Bocharov
NKN. N. Kasatkina
N. N. Kasatkina
ISI. S. Stilidi
I. S. Stilidi
Background. Medicinal plants have a high chemopreventive potential in oncology. The structural diversity of plant biologically active substances: phenolic compounds (simple phenols, flavonoids, phenolic acids, tannins, etc.), terpenoids (mono-, diterpenoids, triterpene saponins, etc.), essential oils, for example, results in a wide range of antitumor activity. Complex herbal preparations are more effective and safe due to their multi-target effects on various regulatory mechanisms in combination with relatively low toxicity. The development of effective natural pharmaceutical compositions based on the structural diversity of biologically active substances seems relevant.Aim. Number plant extracts antiproliferative effect against CaOv human ovarian adenocarcinoma cells investigation and potential phytocomponents selection for the novel antitumor pharmaceutical composition development.Materials and methods. CaOv human ovarian adenocarcinoma cell line was used as a test model. The antiproliferative effect of plant extracts was measured by the radiometric method based on the 3H-thymidine incorporation into CaOv cells DNA. Half maximal inhibitory concentration (IC50) was calculated using probit analysis. The selection of vegetable oil as an optimal extraction agent was carried out on C57BL/6 male mice based on the wound healing effect.Results. The antiproliferative activity of 27 medical plant extracts was studied. The 14 most effective ones in these conditions were selected based on the IC50. Linseed oil was chosen as an optimal extraction agent considered the wound-healing effect of individual vegetable oils (linseed, sunflower, corn), as well as the corresponding oil extracts of the phytocomposition.Conclusion. The selected phytocomponents can be used as a foundation for an optimal compound development of a new pharmaceutical composition aimed at chemoprevention in cancer care. The choice of linseed vegetable oil as an experimental phytocomposition extractant is justified.

15 May 2019 in Advances in molecular oncology
Verified
Journal Article
Open access
LKL. A. Kesaeva
L. A. Kesaeva
ABA. Yu. Bulanov
A. Yu. Bulanov
YFYu. P. Finashutina
Yu. P. Finashutina
VTV. V. Tikhonova
V. V. Tikhonova
OSOlga N. Solopova
Olga N. Solopova
AMA. V. Misyurin
A. V. Misyurin
Molecular genetic detection of CALR gene somatic mutations is required for myeloproliferative neoplasms diagnosis and treatment according to the novel WHO clinical recommendations. CALR mutations are found in approximately 25–35 % cases of essential thrombocythemia and primary myelofibrosis and they are associated with benign clinical outcome. In this study we have compared sensitivity and selectivity of seve ral different options of CALR mutation molecular genetic detection in blood samples of 379 CMD patients and 17 healthy donors. Among methods compared in our study there have been conventional polymerase chain reaction with electrophoretic detection, real-time quantitative polymerase chain reaction, direct Sanger sequencing of polymerase chain reaction fragments and polymerase chain reaction high resolution melting curve analysis. By means of melting curve analysis CALR mutations have been found in 97 (25.5 %) patients, whereas in the cases of Sanger sequencing and polymerase chain reaction there have been 87 (23.0 %) and 84 (22.1 %) CALR mutation positive patients respectively.